Literature DB >> 35060564

The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum.

.   

Abstract

Entities:  

Year:  2022        PMID: 35060564      PMCID: PMC8772623          DOI: 10.1097/MD.0000000000028670

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


× No keyword cloud information.
In the article, “The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies”,[ which appears in Volume 100, Issue 50 of Medicine, the authors Bin Cao and Qi Zhang have been added. The corresponding author has been updated from Hui-qing Zhang to Qi Zhang.
  1 in total

1.  The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies.

Authors:  Bin Cao; Qian Wang; Xiao-Li Fu; Guo-Dong Wei; Long Zhao; Pei-Jun Zhang; Dairong Li; Hui-Qing Zhang; Qi Zhang
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.